INMB
INmune Bio (INMB)
$77
About INmune Bio (INMB)
INmune Bio, Inc. is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprogram the immune system to fight cancer and Alzheimer’s disease. Its product pipeline includes INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer and TRD, and LIVNate. The company was founded by Mark Lowdell on September 25, 2015 and is headquartered in Boca Raton, FL.
Details
Daily high
$8.06
Daily low
$7.63
Price at open
$7.63
52 Week High
$11.30
52 Week Low
$4.32
Market cap
180.3M
Dividend yield
0.00%
Volume
342,676
Avg. volume
249,246
P/E ratio
-3.98
INmune Bio News
Details
Daily high
$8.06
Daily low
$7.63
Price at open
$7.63
52 Week High
$11.30
52 Week Low
$4.32
Market cap
180.3M
Dividend yield
0.00%
Volume
342,676
Avg. volume
249,246
P/E ratio
-3.98